Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The refrigerant industry is experiencing a high level of prosperity, with the company's performance expected to continue its strong growth [6] - The profitability of fluoropolymer materials is gradually recovering, driven by increased production and improved market conditions [6] Financial Performance Summary - In 2024, the company achieved operating revenue of 4.61 billion yuan, a year-on-year increase of 5.4%, and a net profit attributable to shareholders of 250 million yuan, up 36.8% year-on-year [4][7] - The company's Q4 2024 results showed operating revenue of 1.23 billion yuan, a year-on-year increase of 7.6%, and a net profit of 105 million yuan, up 385% year-on-year [5] - For Q1 2025, the company reported operating revenue of 1.14 billion yuan, a year-on-year increase of 12.4%, and a net profit of 97 million yuan, up 161.7% year-on-year [10] Product Segment Performance - In the fluorocarbon chemical segment, the company generated revenue of 2.447 billion yuan in 2024, with an average gross margin of 20.37%, up 12.62 percentage points year-on-year [7][9] - The fluoropolymer materials segment achieved revenue of 1.581 billion yuan in 2024, reflecting a year-on-year increase of 17.38% [7][9] - The chemical raw materials segment saw a revenue decline to 436 million yuan in 2024, with a significant drop in average selling price [9] Future Projections - The company is projected to achieve operating revenues of 5.012 billion yuan, 5.433 billion yuan, and 5.853 billion yuan for 2025, 2026, and 2027 respectively, with net profits of 491 million yuan, 589 million yuan, and 680 million yuan [11][13] - The expected price-to-earnings ratios for the next three years are 20, 17, and 15 times [11]

Core Viewpoint - Yonghe Co., Ltd. has demonstrated significant growth in both revenue and profit in its 2024 annual report, indicating strong performance in the fluorochemical industry and effective utilization of market opportunities [1][2]. Financial Performance - In 2024, Yonghe Co., Ltd. reported a revenue of 4.606 billion yuan, a year-on-year increase of 5.42%, and a net profit attributable to shareholders of 251 million yuan, up 36.83% [1]. - The company's net profit excluding non-recurring items reached 246 million yuan, reflecting a substantial growth of 117.8% year-on-year [1]. - For Q1 2025, the company achieved a revenue of 1.138 billion yuan, representing a 12.36% increase compared to the same period last year, with a net profit of 97.39 million yuan, up 161.66% [1]. Industry Position and Strategy - Yonghe Co., Ltd. has established itself as a comprehensive fluorochemical enterprise, covering the entire industry chain from raw material mining to production and sales, making it one of the most complete fluorochemical industry chains in China [1]. - The company has benefited from policy and market opportunities, achieving synergistic development in fluorocarbon chemicals, fluoropolymer materials, and fine fluorochemical products, with a nationwide sales network and international channels covering over 100 countries [1]. Market Dynamics - The implementation of production quotas for HFCs refrigerants in 2024 has altered the competitive landscape, leading to increased industry concentration and tighter supply-demand balance, which has driven significant price increases for refrigerants [2]. - In 2024, the fluorocarbon chemicals business generated a revenue of 2.4467353 billion yuan, a year-on-year increase of 3.78%, with an average gross margin of 20.37%, up 12.62% from the previous year [2]. - The company received a total quota of 61,400 tons for HCFCs and HECs refrigerants in 2025, with HFCs product quota at 58,200 tons, positioning it among the industry leaders [2]. Product Performance - Despite general pressure on fluoropolymer materials leading to a "volume increase, price decrease" scenario, certain products like HFP have shown price stabilization since Q4 2024, improving profitability [2]. - The sales volume of fluoropolymer materials reached 38,635.68 tons, a year-on-year increase of 40.59%, with revenue for this segment at 1.5811074 billion yuan, up 17.38% [2]. Future Outlook - Yonghe Co., Ltd. plans to continue its global business expansion and leverage its full industry chain advantages, focusing on high-end fluoropolymer materials, new environmentally friendly refrigerants, and fine fluorochemical development [3]. - The company aims to enhance its product variety and quality, striving to become a leading professional fluorochemical enterprise in China, characterized by comprehensive offerings, environmental sustainability, and high quality [3].

Core Viewpoint - Yonghe Co. reported a revenue of 4.61 billion yuan for 2024, a year-on-year increase of 5.4%, and a net profit attributable to shareholders of 251 million yuan, up 37% year-on-year [1] Group 1: Financial Performance - In Q4 2024, the company achieved a revenue of 1.23 billion yuan, an increase of 8% year-on-year and 2% quarter-on-quarter, with a net profit of 105 million yuan, up 385% year-on-year and 210% quarter-on-quarter [1] - For Q1 2025, the company reported a revenue of 1.14 billion yuan, a year-on-year increase of 12% but a quarter-on-quarter decrease of 7%, with a net profit of 97 million yuan, up 162% year-on-year and down 7% quarter-on-quarter [1] - The company proposed a dividend of 0.25 yuan per share (before tax) for 2024, with a payout ratio of 47% [1] Group 2: Industry Insights - In 2024, the refrigerant sector saw a recovery in market conditions, while the fluoropolymer and chemical raw materials segments faced declining profit margins [1] - The sales volume of fluorocarbon chemicals decreased by 9.2% year-on-year to 103,000 tons, but revenue increased by 3.8% to 2.45 billion yuan, with a gross margin up 13 percentage points to 20.4% [1] - The sales volume of fluoropolymers increased by 41% year-on-year to 39,000 tons, with revenue rising 17% to 1.58 billion yuan, although the gross margin fell by 8 percentage points to 15.8% due to price declines [1] - The sales volume of chemical raw materials increased by 14% year-on-year to 240,000 tons, but revenue decreased by 20% to 440 million yuan, with a gross margin down 16 percentage points to -9.3% due to significant price drops [1] Group 3: Future Outlook - In Q1 2025, the sales volume of fluorocarbon chemicals increased by 3.6% year-on-year to 21,000 tons, with revenue up 25% to 590 million yuan, indicating continued improvement in the refrigerant market [2] - The average price of refrigerants increased by 21% year-on-year and 10% quarter-on-quarter to 28,000 yuan per ton [2] - The company expects to enhance its competitiveness in the fluorochemical industry with the successful commissioning of new projects, including 4,000 tons/year of perfluorohexanone and 8,000 tons/year of VDF [2] Group 4: Profit Forecast and Valuation - The company has adjusted its profit forecasts for 2025-2027, expecting net profits of 450 million, 560 million, and 640 million yuan respectively, reflecting an upward adjustment of 12% and 8% for 2025 and 2026 [3] - The target price for the company is set at 23.04 yuan, up from a previous value of 19.08 yuan, based on a 24x PE ratio for 2025 [3]

Investment Rating - The report maintains an "Overweight" rating for the company [7] Core Views - The company achieved a revenue of 4.61 billion RMB in 2024, a year-on-year increase of 5.4%, and a net profit attributable to shareholders of 251 million RMB, up 37% year-on-year [1] - The refrigerant sector is experiencing favorable conditions, leading to an upward adjustment in profit forecasts for the company [4] - The company is expected to benefit from the successful launch of new projects and improved competitiveness in the fluorochemical industry [3] Summary by Sections Financial Performance - In Q4 2024, the company reported a revenue of 1.23 billion RMB, a year-on-year increase of 8% and a net profit of 105 million RMB, up 385% year-on-year [1] - For Q1 2025, the company achieved a revenue of 1.14 billion RMB, a year-on-year increase of 12%, with a net profit of 97 million RMB, up 162% year-on-year [1] Market Conditions - The sales volume of fluorocarbon chemicals in 2024 decreased by 9.2% to 103,000 tons, but revenue increased by 3.8% to 2.45 billion RMB, with a gross margin increase of 13 percentage points to 20.4% [2] - The company’s fluoropolymer sales increased by 41% year-on-year to 39,000 tons, with revenue rising by 17% to 1.58 billion RMB, although gross margin decreased by 8 percentage points to 15.8% due to price declines [2] Profit Forecast and Valuation - The company’s net profit forecasts for 2025-2027 are adjusted to 450 million RMB, 560 million RMB, and 640 million RMB respectively, with corresponding EPS of 0.96, 1.18, and 1.37 RMB [4] - The target price for the company is set at 23.04 RMB, reflecting a 24x PE ratio for 2025, up from a previous target of 19.08 RMB [4]

浙江永和制冷股份有限公司 2024 年年度独立董事述职报告（李清伟） 本人作为浙江永和制冷股份有限公司（以下简称"公司"）独立董事，在 2024 年履职期间，严格遵守《中华人民共和国公司法》《中华人民共和国证券 法》《上市公司独立董事管理办法》以及公司《独立董事工作制度》等相关规定， 认真履行工作职责，为公司的规范运作与科学决策提供了专业依据，现就本人 2024 年履职期间工作情况报告如下： 一、独立董事的基本情况 （一）公司独立董事人员情况 公司董事会由 9 名董事组成，其中独立董事 3 人，占董事会人数的三分之一， 符合有关法律法规及《公司章程》的规定。 （二）本人基本情况 本人李清伟，1963 年出生，法学博士，教授。中国国籍，无境外永久居留 权。曾任河南师范大学法学院助教，后历任上海财经大学法学院讲师、副教授、 教授，现任上海大学法学院教授。现任爱丽家居科技股份有限公司、张家港保税 科技（集团）股份有限公司、长盛基金管理有限公司独立董事及上海董道律师事 务所兼职律师。2023 年 8 月至今，任公司独立董事。 （三）独立性情况说明 在 2024 年履职期间，本人严格遵守《上市公司独立董事管理办法》第六 ...

（一）公司独立董事人员情况 公司董事会由 9 名董事组成，其中独立董事 3 人，占董事会人数的三分之一， 符合有关法律法规及《公司章程》的规定。 2024 年年度独立董事述职报告（王建中） 本人作为浙江永和制冷股份有限公司（以下简称"公司"）独立董事，在 2024 年履职期间，严格遵守《中华人民共和国公司法》《中华人民共和国证券 法》《上市公司独立董事管理办法》以及公司《独立董事工作制度》等相关规定， 认真履行工作职责，为公司的规范运作与科学决策提供了专业依据，现就本人 2024 年履职期间工作情况报告如下： 一、独立董事的基本情况 浙江永和制冷股份有限公司 （二）本人基本情况 王建中，1957 年出生，本科学历，高级工程师。中国国籍，无境外永久居 留权。曾就职于上海市有机氟材料研究所、上海三爱富新材料股份有限公司。2000 年起兼任中国氟硅有机材料工业协会副秘书长、理事、有机氟专业委员会秘书长、 专家委员会委员，现任中国氟硅有机材料工业协会副总工程师、氟化工专家委员 会秘书长。2023 年 8 月至今，任公司独立董事。 （三）独立性情况说明 在 2024 年履职期间，本人严格遵守《上市公司独立董事管理办法》 ...

浙江永和制冷股份有限公司 2024 年度独立董事述职报告（胡继荣） 本人作为浙江永和制冷股份有限公司（以下简称"公司"）独立董事，在 2024 年履职期间，严格遵守《中华人民共和国公司法》《中华人民共和国证券 法》《上市公司独立董事管理办法》以及公司《独立董事工作制度》等相关规定， 认真履行工作职责，为公司的规范运作与科学决策提供了专业依据，现就本人 2024 年履职期间工作情况报告如下： 一、独立董事的基本情况 （一）公司独立董事人员情况 公司董事会由 9 名董事组成，其中独立董事 3 人，占董事会人数的三分之一， 符合有关法律法规及《公司章程》的规定。 （二）本人基本情况 本人胡继荣，1956 年出生，工商管理学硕士，教授，注册会计师。中国国 籍，无境外永久居留权。曾任扬州大学水利建筑工程学院助教、扬州大学商学院 讲师，历任福州大学经济与管理学院副教授、教授。现任龙洲集团股份有限公司、 福建榕基软件股份有限公司、福建富兰光学股份有限公司（IPO）独立董事。2022 年 2 月至今，任公司独立董事。 （三）独立性情况说明 在 2024 年履职期间，本人严格遵守《上市公司独立董事管理办法》第六条 规定的独立性 ...

公司代码：605020 公司简称：永和股份 债券代码：111007 债券简称：永和转债 浙江永和制冷股份有限公司 2024年度内部控制评价报告 浙江永和制冷股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内部 控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办法，在内部控制日常监督和专项 监督的基础上，我们对公司2024年12月31日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露内 部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责组织 领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存 在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连带法 律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整，提 高经营效率和效果，促进实现发展战略。由于内部控制存在的固有局限性，故仅能为实现上述目 ...

本次担保预计金额及实际为其提供的担保余额：公司预计 2025 年度为合并 报表范围内子公司新增担保额度不超过 430,000.00 万元。截至 2025 年 3 月 31 日， 公司及子公司对外担保余额为 54,969.85 万元，均为公司对子公司的担保。 特别风险提示：公司本次担保对象包头永和新材料有限公司、浙江冰龙环保 科技有限公司为资产负债率 70%以上的公司，敬请投资者关注担保风险。 | 证券代码：605020 | 证券简称：永和股份 公告编号：2025-034 | | --- | --- | | 债券代码：111007 | 债券简称：永和转债 | 浙江永和制冷股份有限公司 关于 2025 年度对公司合并报表范围内担保额度预计 的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 被担保人：公司合并报表范围内的下属企业邵武永和金塘新材料有限公司、 包头永和新材料有限公司、浙江冰龙环保科技有限公司，均为公司子公司，不属于 公司关联人。 为满足浙江永和制冷股份有限公司（以下简称"公司"）下属子公司的生产经 ...

| 证券代码：605020 | 证券简称：永和股份 | 公告编号：2025-037 | | --- | --- | --- | | 债券代码：111007 | 债券简称：永和转债 | | 浙江永和制冷股份有限公司 关于调整部分募集资金投资项目投资总额并延期的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 拟调整投资总额的项目名称及情况：基于"邵武永和年产 10kt 聚偏氟乙烯 和 3kt 六氟环氧丙烷扩建项目"实际投资建设情况及未来资金安排，公司拟将其 投资总额由 30,661.57万元调整至 37,711.78万元，超出部分公司将以自筹方式解决。 拟实施延期项目的名称及情况：根据募投项目实际建设情况，同时考虑市 场环境等多种因素，为了维护全体股东和企业利益，公司拟在不改变募投项目实 施主体、募集资金用途的情况下，对"邵武永和新型环保制冷剂及含氟聚合物等 氟化工生产基地项目""邵武永和年产 10kt 聚偏氟乙烯和 3kt 六氟环氧丙烷扩建 项目"达到预定可使用状态的时间进行调整，将上述项目完成时间由 2 ...